AT
AU
BE
BG
CA
CH
CN
CZ
DE
DK
ES
EU
FI
FR
GR
HU
IE
IN
IT
JP
NL
NO
PL
PT
RU
SE
UK
ZA
Alert: Product and Safety NoticeMeet IQcast, the Newest Addition to the Sugar.IQ assistant
Over the last few months, it’s been great to hear the positive feedback from those of you using the Guardian Connect Smart CGM with the Sugar.IQ assistant. Today, the system gets even smarter, with IQcast technology, a new addition to the Sugar.IQ assistant experience.
The IQcast feature is like a weather forecast for your diabetes. Using artificial intelligence technology from our partnership with IBM Watson Health, the Sugar.IQ assistant can now forecast if you’re likely to have a low 1-4 hours in advance, giving you the opportunity to plan ahead.
We know this heads-up can make a big difference. Instead of guessing if a low might be coming – or worse, not knowing – you have technology working for you to help you be proactive in your diabetes management. Armed with this forecast, you might want to eat a snack, change the timing of your next meal, or keep a closer eye on y
our glucose trend. With this technology, you can really live in the moment and focus on what matters – your family and friends.
This is just the first of many updates and additions we plan to make with the Sugar.IQ assistant. But your feedback is really important. So, if you’re already using the Sugar.IQ assistant, tell us in the comments what improvements and updates you’d like to see. And if you’re using the Guardian Connect Smart CGM, download the Sugar.IQ assistant today.
As a reminder, these products are useful for those managing their diabetes with multiple daily injections. We know many of our pumpers are interested in similar technology—particularly the ability to see glucose numbers on a smartphone. We are working on that functionality and will be sure to share updates with the community as soon as we can.
Important Safety Information
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and www.medtronicdiabetes.com/importantsafetyinformation.
The Sugar.IQ™ app (MMT-8100) helps manage diabetes by facilitating the logging and display of meal entries and sensor glucose (SG) data, tracking meal log entries, reporting insights of how meals affect glucose levels, and supporting good choices and trends with motivational messages. The app serves as an additional display for real-time CGM data from the Guardian™ .
Connect system through the CareLink™ Personal software. It is not intended to provide medical advice and should not be relied upon for such purpose. The app is not intended to replace the real-time display of the CGM data on the Guardian™ Connect app, control any functions of the connecting device, calculate insulin or other drug doses, or modify data or control functions of the Guardian Connect system. All therapy decisions should be made by the app user based on blood glucose (BG) measurements obtained from a BG meter. Changes to treatment should only be made in consultation with a healthcare professional (HCP). For complete details, consult the user guide at http://www.medtronicdiabetes.com/download-library.
Related Post
About Author
Pam Reese
Pam ReesePamela Reese joined Medtronic in 2014, where she leads external communications for the Diabetes Group at Medtronic. She enjoys connecting with people in the diabetes community and getting to know the doctors and educators who devote their lives to helping people with diabetes live healthier lives. Pamela has spent her career in running public relations programs for both large and small technology companies. She earned a Bachelors degree in communication from Boston University. When not helping the public understand what Medtronic is working on, Pamela enjoys spending time with her husband and two daughters.
I would like to know if there is an estimated date for compatibility of the Guardian Connect App with 670G? I just found out about the app, dowloaded it and tried to hook up my transmitter, without success and was very disappointed.
I certainly understand, Lisa. Unfortunately, due to FDA guidelines, we’re not allowed to discuss products before they are approved. We know how important these features are to our customers and will share more information as it becomes available.
Hi I was wondering if the CGM data/graph on sugar IQ app is real time data? like the guardian connect app that provides immediate glucose value.
Great question, Tina! The Sugar.IQ app receives data from the Guardian Connect system through the CareLink Personal website.
A delay of up to 10 minutes may occur between the Guardian Connect app and the Sugar.IQ app. The Guardian Connect app should be the primary point of reference for real-time data.
Will the IQ app come to Europe when the new blue-toothed pumps come?
Hi Linnea. You’ve reached the US team and we’re not able to speak to products that have not been approved or are available outside the US. We encourage you to reach out to your local team, which can be found here: http://bit.ly/1ce3pEc, to discuss your available options and for the most up to date information.
Do you know when medicade will cover cgms I gave emailed almost ever political person including the president of u.s. have not herd anything.so I ask you medicade not medicare.medicadegoing to cover your cgms
Thanks for reaching out, Leona. Currently, Medicare does not cover our CGM, but we are working on with them and the FDA on updated labeling as we work towards coverage approval. In the meantime, if you’d like to discuss your options for financial assistance or payment plans, please give our team a call at 800.646.4633, option 3.
Android support coming soon?
Devon, unfortunately, I don’t have a timeline to share for Android compatibility, but our team is working hard to make this available. As soon as we have additional information, we’ll be sure to share it with our community.
Hi – I currently have the 670G and the Guardian Sensor 5. In order to get the Sugar I.Q. would I have to get a new transmitter?
Belinda, the Guardian Connect CGM system featuring Sugar.IQ is a tool that helps people on multiple daily injection therapy better manage their diabetes by providing predictive insights and helpful information about behaviors that might be impacting glucose levels. This system is not designed to be compatible with the MiniMed 670G system because while that system also provides predictive alerts, it automatically makes adjustments for you to help keep glucose levels in range. The pump essentially takes on much of the manual work whereas the Guardian Connect CGM system provides information and insights to help users make their own adjustments. We hope this helps – let us know if you have additional questions or suggestions about the technology!
Will Sugar I.Q be released in Europe sometime ??
Hi, Linnea. This is a good conversation to have with your local team. They will have the most current updates available for our available products.